Market revenue in 2023 | USD 1,514.1 million |
Market revenue in 2030 | USD 2,277.7 million |
Growth rate | 6% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Frozen Nondonor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.29% in 2023. Horizon Databook has segmented the Germany in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
Medical tourism is growing in Germany owing to the presence of liberal laws pertaining to ART in the country. There has been a growing demand for IVF treatments in Germany, driven by factors such as delayed parenthood, changing social norms, and increasing awareness & acceptance of ARTs.
Furthermore, Germany is renowned for its advancements in medical technology and research. Technological innovations in IVF procedures, such as improved embryo selection techniques, genetic testing, & cryopreservation methods, have increased the success rates of IVF treatments and expanded the options available to patients.
Market players are making strategic new launches to leverage the growing demand, as well as to gain a stronger market position. In April 2022, Apryl, a Berlin-based company, successfully raised USD 4.85 million in a funding round led by Breega.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into Germany in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account